Occam Global is an international executive recruiting and leadership advisory firm specializing in building management teams for innovative companies in the life sciences, AI, robotics, defense, technology, and venture capital sectors.
The firm’s unique competence lies in a proven ability to attract exceptional business and scientific leaders, fluid access to uncommon talent, and an enduring commitment to results informed by elevated ethics and enlightened aggression.
As a result, Occam has established itself as a leading search partner for entrepreneurs, investors, and corporations globally. Our success is rooted in cultivating and valuing relationships, establishing trust with entrepreneurs, executives, and investors, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.
Each in our own fashion, we sat in the mud in 2012. I had just retired from a 25-year career at Fidelity Investments and moved from Boston to New York. John had just completed his MBA without much of a clue as to how to build his career anew after having toiled for a decade on Wall Street.
With common resolution, an intergenerational conspiracy was hatched, one which allowed us to reinvent ourselves. We reached for the stars in creating a family business. I would find a new creative platform to ply a trade honed over three decades in Boston and John would get a fresh start in a business which he had witnessed me practice throughout his youth.
Thus, Occam was born. A fusion of hard-earned wisdom and amorphous creative vigor. Our collaboration has yielded a richly successful global search firm, one dedicated to helping entrepreneurs realize their vision. Occam’s culture is rooted in intuitive team play, mutual respect, warmth of spirit, uncompromising ethics and clarity of purpose – family values.
We built our firm on the pillars of objectivity, undiluted ethics, and enlightened aggression.
With a process that’s rooted in relationships, data, and intellect, we’ve provided professional judgments that have made a lasting impact on our partners.
Our judgements are simultaneously inspired by instinct and pragmatism, resulting in balanced outcomes designed to endure.
In May 2025, Occam Global, a leading biotech executive recruiting firm, placed Angus Sinclair, PhD, as Chief Scientific Officer at London-based LabGenius Therapeutics. As CSO, Sinclair will leverage his extensive experience in drug discovery to lead LabGenius’ scientific strategy, driving innovation in both pipeline and platforms. Angus joins LabGenius from IGM Biosciences, where he was
Metsera (Nasdaq: MTSR) is a clinical-stage biotech focused on developing the next generation of medicines for obesity and metabolic disease. In May 2025, Occam placed Matt Lang as its Chief Legal Officer & Corporate Secretary. Prior to Metsera, Matt had a multidimensional business career culminating in his service as Chief Business & Legal Officer of
In May 2025, Occam Global recruited Jay Barth, MD as CMO of eGenesis. Dr. Barth is a serial biotech CMO with rich experience shepherding the clinical progress of novel modalities across diverse disease states. He joins eGenesis from Ascidian Therapeutics, where he led the company’s RNA Exon Editing technology into the clinic. His prior roles include that of CMO for orphan
In early 2025, Occam Global placed McDavid Stilwell as CFO of CPTx, a company pioneering the development of in vivo genetic medicines built on single-stranded DNA. CPTx’s lead development programs include a next-generation in vivo CAR-T therapy and a novel, programmable, non-viral self-delivering gene nanocarrier. Stilwell is an industry veteran with more than 25 years
Case Studies
Read about how Occam Global is helping innovative organizations tackle their biggest executive recruitment challenges
Blog & Insights
Discover new tips, industry news and guides by Occam Global
-Latest Interview: Whit Bernard, CEO of Metsera